Belite Bio, Inc (BLTE)

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $6.56 billion. The enterprise value is $6.02 billion.

Market Cap	6.56B
Enterprise Value	6.02B

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 39.34 million shares outstanding. The number of shares has increased by 9.82% in one year.

Current Share Class	n/a
Shares Outstanding	39.34M
Shares Change (YoY)	+9.82%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	1.78%
Owned by Institutions (%)	10.59%
Float	18.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.45
P/TBV Ratio	8.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 50.02, with a Debt / Equity ratio of 0.00.

Current Ratio	50.02
Quick Ratio	49.90
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42,104.00

Financial Efficiency

Return on equity (ROE) is -16.94% and return on invested capital (ROIC) is -11.48%.

Return on Equity (ROE)	-16.94%
Return on Assets (ROA)	-11.29%
Return on Invested Capital (ROIC)	-11.48%
Return on Capital Employed (ROCE)	-10.93%
Weighted Average Cost of Capital (WACC)	-2.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.89M
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +189.89% in the last 52 weeks. The beta is -1.22, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.22
52-Week Price Change	+189.89%
50-Day Moving Average	170.26
200-Day Moving Average	121.22
Relative Strength Index (RSI)	46.90
Average Volume (20 Days)	162,922

Short Selling Information

The latest short interest is 1.04 million, so 5.05% of the outstanding shares have been sold short.

Short Interest	1.04M
Short Previous Month	990,833
Short % of Shares Out	5.05%
Short % of Float	n/a
Short Ratio (days to cover)	5.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-84.21M
Pretax Income	-77.61M
Net Income	-77.61M
EBITDA	-84.02M
EBIT	-84.21M
Earnings Per Share (EPS)	-$2.31

Balance Sheet

The company has $492.42 million in cash and $429,000 in debt, with a net cash position of $491.99 million or $12.51 per share.

Cash & Cash Equivalents	492.42M
Total Debt	429,000
Net Cash	491.99M
Net Cash Per Share	$12.51
Equity (Book Value)	770.49M
Book Value Per Share	19.59
Working Capital	484.39M

Cash Flow

In the last 12 months, operating cash flow was -$36.99 million and capital expenditures -$178,000, giving a free cash flow of -$37.17 million.

Operating Cash Flow	-36.99M
Capital Expenditures	-178,000
Depreciation & Amortization	184,000
Net Borrowing	n/a
Free Cash Flow	-37.17M
FCF Per Share	-$0.94

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.82%
Shareholder Yield	-9.82%
Earnings Yield	-1.19%
FCF Yield	-0.57%

Analyst Forecast

The average price target for Belite Bio is $198.00, which is 18.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$198.00
Price Target Difference	18.79%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2